{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:15:26Z","timestamp":1774908926993,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.rceng.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T18:54:53Z","timestamp":1737658493000},"page":"157-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical presentation of pheochromocytoma and screening recommendations"],"prefix":"10.1016","volume":"225","author":[{"given":"O.F.","family":"Arroyo Ripoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Achote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"M.","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2025.01.004_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0010","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.rceng.2025.01.004_bib0015","unstructured":"Phaeochromocytoma in the rat; pathogenesis and collateral reactions and its relation to comparable tumours in man [Accessed 3 August 2024]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/13042774\/."},{"key":"10.1016\/j.rceng.2025.01.004_bib0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1210\/js.2017-00208","article-title":"Max Schottelius: pioneer in pheochromocytoma","volume":"1","author":"Bausch","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.rceng.2025.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.eprac.2022.09.003","article-title":"New biology of pheochromocytoma and paraganglioma","volume":"28","author":"Pacak","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.rceng.2025.01.004_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-018-0804-z","article-title":"Pheochromocytomas and hypertension","volume":"20","author":"Pappachan","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.rceng.2025.01.004_bib0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rceng.2025.01.004_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rceng.2025.01.004_bib0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.medcli.2024.03.025","article-title":"Pheochromocytoma. Preoperative approach","volume":"163","author":"Araujo-Castro","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.01.004_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jacc.2020.04.080","article-title":"Pathophysiology and acute management of tachyarrhythmias in pheochromocytoma: JACC review topic of the week","volume":"76","author":"Nazari","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients","volume":"150","author":"Baguet","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.rceng.2025.01.004_bib0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.rceng.2025.01.004_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Soltani","year":"2016","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.rceng.2025.01.004_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0042-100911","article-title":"Clinical and pathological characteristics of hypertensive and normotensive adrenal pheochromocytomas","volume":"124","author":"Lu","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.rceng.2025.01.004_bib0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2265.1992.tb02326.x","article-title":"Phaeochromocytomas as a cause of hypotension","volume":"37","author":"Baxter","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2169\/internalmedicine.44.222","article-title":"Pheochromocytoma presenting as recurrent hypotension and syncope","volume":"44","author":"Ueda","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.rceng.2025.01.004_bib0095","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.rceng.2025.01.004_bib0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S2213-8587(23)00256-5","article-title":"Catecholamine-induced hypertensive crises: current insights and management","volume":"11","author":"Nazari","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0105","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1097\/MD.0000000000002198","article-title":"Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review","volume":"94","author":"Batisse-Lignier","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP.14.9.1137","article-title":"Catecholamine-induced cardiomyopathy","volume":"14","author":"Kassim","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.rceng.2025.01.004_bib0115","doi-asserted-by":"crossref","first-page":"1204851","DOI":"10.3389\/fendo.2023.1204851","article-title":"Pheochromocytoma\/paraganglioma-associated cardiomyopathy","volume":"14","author":"Szatko","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0120","first-page":"375","article-title":"A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma","volume":"3","author":"Imperadore","year":"2002","journal-title":"Ital Heart J"},{"key":"10.1016\/j.rceng.2025.01.004_bib0125","first-page":"e4551","article-title":"Glycemic disturbances in pheochromocytoma and paraganglioma","volume":"11","author":"Ronen","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.rceng.2025.01.004_bib0130","doi-asserted-by":"crossref","first-page":"593780","DOI":"10.3389\/fendo.2020.593780","article-title":"Glucose intolerance on phaeochromocytoma and paraganglioma \u2014 the current understanding and clinical perspectives","volume":"11","author":"Abe","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0135","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2017-00357","article-title":"Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma","volume":"102","author":"Komada","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.01.004_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dmr.5610040104","article-title":"Regulation of glucose metabolism by sympathochromaffin catecholamines","volume":"4","author":"Clutter","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.rceng.2025.01.004_bib0145","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.3390\/ijms24065153","article-title":"Pathophysiology and management of glycemic alterations before and after surgery for pheochromocytoma and paraganglioma","volume":"24","author":"Lopez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rceng.2025.01.004_bib0150","doi-asserted-by":"crossref","first-page":"12676","DOI":"10.3390\/ijms241612676","article-title":"Diabetes mellitus secondary to endocrine diseases: an update of diagnostic and treatment particularities","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rceng.2025.01.004_bib0155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00004872-200309000-00020","article-title":"Diabetes as a marker of pheochromocytoma in hypertensive patients","volume":"21","author":"La Batide-Alanore","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.rceng.2025.01.004_bib0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12020-023-03492-7","article-title":"Secondary diabetes mellitus in pheochromocytomas and paragangliomas","volume":"82","author":"Moustaki","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.rceng.2025.01.004_bib0165","article-title":"Unusual presentation of phaeochromocytoma","volume":"2016","author":"Hope","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rceng.2025.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1245\/s10434-016-5701-6","article-title":"Resection of pheochromocytoma improves diabetes mellitus in the majority of patients","volume":"24","author":"Beninato","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/ERC-22-0218","article-title":"Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas","volume":"29","author":"Araujo-Castro","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.rceng.2025.01.004_bib0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.surg.2014.08.020","article-title":"Hypoglycemia after resection of pheochromocytoma","volume":"156","author":"Chen","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.rceng.2025.01.004_bib0185","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jc.2003-030000","article-title":"Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma","volume":"88","author":"Wiesner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.01.004_bib0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14310\/horm.2002.1184","article-title":"Insulin resistance in pheochromocytoma improves more by surgical rather than by medical treatment","volume":"2","author":"Diamanti-Kandarakis","year":"2003","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5173\/ceju.2014.04.art9","article-title":"The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study","volume":"67","author":"Pogorzelski","year":"2014","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/iju.IJU_190_18","article-title":"Changes in blood pressure, blood sugar, and quality of life in patients undergoing pheochromocytoma surgery: a prospective cohort study","volume":"35","author":"Prakash","year":"2019","journal-title":"Indian J Urol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0205","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.asjsur.2019.01.012","article-title":"Will the resection of pheochromocytoma improve preoperative diabetes mellitus?","volume":"42","author":"Liu","year":"2019","journal-title":"Asian J Surg"},{"key":"10.1016\/j.rceng.2025.01.004_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","article-title":"Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study","volume":"81","author":"Elenkova","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0215","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","article-title":"Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission","volume":"14","author":"Khatiwada","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.rceng.2025.01.004_bib0220","doi-asserted-by":"crossref","first-page":"E4028","DOI":"10.1210\/clinem\/dgab401","article-title":"Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma","volume":"106","author":"Krumeich","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.01.004_bib0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11427-022-2282-1","article-title":"Factors associated with dysglycemia and its post-surgical resolution in patients with pheochromocytomas","volume":"66","author":"Zhao","year":"2023","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.rceng.2025.01.004_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1507\/endocrj.EJ18-0407","article-title":"Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma","volume":"66","author":"Abe","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.rceng.2025.01.004_bib0235","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EO-22-0044","article-title":"Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes","volume":"2","author":"Turin","year":"2022","journal-title":"Endocr Oncol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12020-010-9319-3","article-title":"Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma","volume":"37","author":"King","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.rceng.2025.01.004_bib0245","article-title":"Phaeochromocytoma with hypercortisolism and hypercalcaemia","volume":"2015","author":"Edafe","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rceng.2025.01.004_bib0250","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s13104-015-1738-z","article-title":"Pheochromocytoma multisystem crisis treated with emergency surgery: a case report and literature review","volume":"8","author":"Kakoki","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.rceng.2025.01.004_bib0255","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.01.004_bib0260","series-title":"Pathology and genetics of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.rceng.2025.01.004_bib0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.rceng.2025.01.004_bib0270","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.01.004_bib0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12672-021-00404-x","article-title":"Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion","volume":"12","author":"Li","year":"2021","journal-title":"Discov Oncol"},{"key":"10.1016\/j.rceng.2025.01.004_bib0280","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ancard.2016.04.016","article-title":"Causes of secondary hypertension in the young population: a monocentric study","volume":"65","author":"Noilhan","year":"2016","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0285","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/jch.14779","article-title":"Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS\/MS analysis of plasma catecholamines and their metabolites","volume":"26","author":"Zhang","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0290","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/clinchem\/hvab064","article-title":"Diagnostic accuracy of salivary metanephrines in pheochromocytomas and paragangliomas","volume":"67","author":"Eijkelenkamp","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.rceng.2025.01.004_bib0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference intervals for LC-MS\/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.rceng.2025.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated o-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.rceng.2025.01.004_bib0305","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00216-020-02436-8","article-title":"Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis","volume":"412","author":"Xiong","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.rceng.2025.01.004_bib0310","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.rceng.2025.01.004_bib0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ando.2009.02.008","article-title":"Biochemical diagnosis of pheochromocytoma and paraganglioma","volume":"70","author":"Lenders","year":"2009","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.rceng.2025.01.004_bib0320","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s40618-021-01649-7","article-title":"Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887425000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887425000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T17:31:10Z","timestamp":1740850270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887425000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2254887425000086"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2025.01.004","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation of pheochromocytoma and screening recommendations","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.10.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}